Circulation of Streptococcus pneumoniae clone Colombia5 ST289 in nine Latin American countries

Revista Panamericana de Salud Publica/Pan American Journal of Public Health

Volumn 25, Issue 4, 2009, Pages 337-343

  Firacative, Carolina ^a   Moreno, Jaime ^a   Resales, Patricia ^b   Maldonado, Aurora ^c   Sánchez, Jacqueline ^d   Pesantes, Carmen ^e   López, Sergio ^f   De Quinzada, Markela ^g   Chamorro, Gustavo ^h   Morales, Sara ⁱ   Spadola, Enza ^j   Gabastou, Jean Marc ^k   Castañeda, Elizabeth ^a  

^a INSTITUTO NACIONAL DE SALUD   (Colombia)

^b Instituto Nacionai de Laboratories de Salud   (Bolivia)

^c INSTITUTO DE SALUD PÚBLICA DE CHILE   (Chile)

^d School of Medicine   (Dominican Republic)

^e Instituto Nacional de Higiene y Medicina Tropical   (Ecuador)

^f Centro Nacionai de Diagnóstico y Referenda   (Nicaragua)

^g Instituto Conmemorativo Gorgas de Estudio de la Salud   (Panama)

^h LABORATORIO CENTRAL DE SALUD PÚBLICA   (Paraguay)

ⁱ INSTITUTO NACIONAL DE SALUD   (Peru)

^j Instituto Nacionai de Higiene Rafael Rangel   (Venezuela)

^k PAN AMERICAN HEALTH ORGANIZATION   (United States)

more..

Author keywords

Electrophoresis gel; Epidemiology molecular; Latin America; Pulsed field; Streptococcus pneumoniae; Surveillance

Indexed keywords

BACTERIUM; CLONE; ELECTROKINESIS; GEL; INVASIVE SPECIES; RELATEDNESS; SURVEY;

STREPTOCOCCUS PNEUMONIAE;

EID: 67849116675     PISSN: 10204989     EISSN: 16805348     Source Type: Journal    
DOI: 10.1590/S1020-49892009000400008     Document Type: Article

References (31)

1. Hausdorff WP, Feikin DR, Klugman KP. Epidemiological differences among pneumococcal serotypes. Lancet Infect Dis. 2005;5(2): 83-93.
2. Department of Health and Human Services (US), Centers for Disease Control and Prevention [homepage on the Internet]. Atlanta: CDC; c2005 [cited 2006 Nov 22]. Pneumonia among children in developing countries; [about 2 screens]. Available from: http://www.cdc.gov/ncidod/dbmd/diseaseinfo/pneumchilddevcount-t. htm.
3. Hausdorff WP, Bryant J, Paradiso PR, Siber GR. Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I. Clin Infect Dis. 2000;30(1):100-21.
4. Hausdorff WP, Bryant J, Kloek C, Paradiso PR, Siber GR. The contribution of specific pneumococcal serogroups to different disease manifestations: implications for conjugate vaccine formulation and use, part II. Clin Infect Dis. 2000;30(1):122-40.
5. McGee L, McDougal L, Zhou J, Spratt BG, Tenover FC, George R, et al. Nomenclature of major antimicrobial-resistant clones of Streptococcus pneumoniae defined by the Pneumococcal Molecular Epidemiology Network. J Clin Microbiol. 2001;39(7):2565-71.
6. Pneumococcal Molecular Epidemiology Network (PMEN) [homepage on the Internet]. Atlanta: PMEN; c2005 [cited 2006 Nov 25]. Available from: http://www.sph.emory.edu/PMEN/index.html.
7. Yother J. Capsules. In: Tuomanen EI, Mitchell TJ, Morrison DA, Spratt BG, editors. The Pneumococcus. Washington: ASM Press; 2004. p. 30-48.
8. Di Fabio JL, Castañeda E, Agudelo CI, De La Hoz F, Hortal M, Camou T, et al. Evolution of Streptococcus pneumoniae serotypes and penicillin susceptibility in Latin America, Sireva-Vigía Group, 1993 to 1999. PAHO Sireva-Vigía Study Group. Pan American Health Organization. Pediatr Infect Dis J. 2001;20(10): 959-67.
9. Camargos P, Fischer GB, Mocelin H, Dias C, Ruvinsky R. Penicillin resistance and serotyp-ing of Streptococcus pneumoniae in Latin America. Paediatr Respir Rev. 2006;7(3):209-14.
10. Tamayo M, Sá-Leão R, Santos Sanches I, Castañeda E, de Lencastre H. Dissemination of a chloramphenicol- and tetracycline-resistant but penicillin-susceptible invasive clone of serotype 5 Streptococcus pneumoniae in Colombia. J Clin Microbiol. 1999;37(7):2337-42.
11. 5-19 in Latin America. J Clin Microbiol. 2002;40(11):3942-50.
12. Organización Panamericana de la Salud; Institute Nacional de Salud Colombia. Programa de vigilancia de los serotipos y resistencia antimicrobiana de Streptococcus pneumoniae y Haemophilus influenzae. Manual de procedimientos. Bogotá: OPS/INSC; 2004 [cited 2006 Nov 25]. p. 41-99. Available from: http://www.paho.org/Spanish/AD/THS/EV/LABS-manual-vigilancia- seroti pos.pdf.
13. National Committee for Clinical Laboratory Standards (US). Performance standards for antimicrobial susceptibility testing. 8th ed. Informational supplement. Vol. 23. M2-A8. Wayne (PA): NCCLS; 2003.
14. Vela MC, Fonseca N, Di Fabio JL, Castañeda E. Presence of international multiresistant clones of Streptococcus pneumoniae in Colombia. Microb Drug Resist. 2001;7(2):153-64.
15. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol. 1995;33(9):2233-9.
16. Firacative C, Moreno J, Castañeda E. Caracterización molecular de aislamientos inva-sores colombianos de Streptococcus pneumoniae serotipo 5, recuperados entre 1994 y 2004. Biomédica. 2006;26(2):295-301.
17. Klugman KP. The successful clones: the vector of dissemination of resistance in Streptococcus pneumoniae. J Antimicrob Chemother. 2002;50 Suppl S2:1-5.
18. Álvarez CA, Cortés JA, Cuervo SI, Saavedra A. Neumonía adquirida en la comunidad (NAC), -¿nuevas guías, nuevos cambios? Infectio. 2002;6(2):121-31.
19. Caballero AS, Martínez E, Giraldo H, Álvarez CA, Torres CA, Saavedra C, et al. Recomendaciones para el diagnóstico, tratamiento y prevention de la neumonía adquirida en la comunidad en adultos. Infectio. 2004,8(1): 8-44.
20. Porat N, Trefler R, Dagan R. Persistence of two invasive Streptococcus pneumoniae clones of serotypes 1 and 5 in comparison to that of multiple clones of serotypes 6B and 23F among children in southern Israel. J Clin Microbiol. 2001;39(5):1827-32.
21. Greenberg D, Dagan R, Muallem M, Porat N. Antibiotic-resistant invasive pediatric Streptococcus pneumoniae clones in Israel. J Clin Microbiol. 2003;41(12)5541-5.
22. Serrano I, Melo-Cristino J, Carriço JA, Ramirez M. Characterization of the genetic lineages responsible for pneumococcal invasive disease in Portugal. J Clin Microbiol. 2005; 43(4):1706-15.
23. Ip M, Lyon DJ, Yung RW, Chan C, Cheng AF. Evidence of clonal dissemination of multidrug-resistant Streptococcus pneumoniae in Hong Kong. J Clin Microbiol. 1999-47(9): 2834-9.
24. Hausdorff WP. The roles of pneumococcal serotypes 1 and 5 in paediatric invasive disease. Vaccine. 2007;25(13):2406-12.
25. Henriques Normark B, Kalin M, Örtqvist A, Akerlund T, Liljequist BO, Hedlund J, et al. Dynamics of penicillin-susceptible clones in invasive pneumococcal disease. J Infect Dis. 2001;184(7):861-9.
26. Sandgren A, Sjöström K, Olsson-Liljequist B, Christensson B, Samuelsson A, Kronvall G, et al. Effect of clonal and serotype-specific properties on the invasive capacity of Streptococcus pneumoniae. J Infect Dis. 2004;189(5):785-96.
27. Brueggemann AB, Spratt BG. Geographic distribution and clonal diversity of Streptococcus pneumoniae serotype 1 isolates. J Clin Microbiol. 2003;41(11):4966-70.
28. Harrington SM, Stock F, Kominski AL, Campbell JD, Hormazabal JC, Livio S, et al. Genotypic analysis of invasive Streptococcus pneumoniae from Mali, Africa, by semiautomated repetitive-element PCR and pulsed-field gel electrophoresis. J Clin Microbiol. 2007;45(3):707-14.
29. Adegbola RA, Hill PC, Secka O, Ikumapayi UN, Lahai G, Greenwood BM, et al. Serotype and antimicrobial susceptibility patterns of isolates of Streptococcus pneumoniae causing invasive disease in The Gambia 1996-2003. Trop Med Int Health. 2006;11(7):1128-35.
30. Paul J, Bates J, Kimari J, Gilks C. Serotypes and antibiotic susceptibilities of Streptococcus pneumoniae in Nairobi, Kenya. J Infect. 1996; 32(2):139-42.
31. Vallès X, Flannery B, Roca A, Mandomando I, Sigaúque B, Sanz S, et al. Serotype distribution and antibiotic susceptibility of invasive and nasopharyngeal isolates of Streptococcus pneumoniae among children in rural Mozambique. Trop Med Int Health. 2006;11(3):358-66.